(Q79772239)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17299523%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

title

Inhibition of the mammalian target of rapamycin impedes lymphangiogenesis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17299523%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17299523%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

author name string

Huber S

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17299523%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Bruns CJ

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17299523%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Schmid G

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17299523%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Conrad C

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17299523%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Niess H

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17299523%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Huss R

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17299523%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Graeb C

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17299523%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Jauch KW

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17299523%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Heeschen C

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17299523%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Guba M

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17299523%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

language of work or name

English

0 references

publication date

14 February 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17299523%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17299523%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

volume

71

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17299523%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17299523%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

page(s)

771-777

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17299523%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.ki.5002112

25 December 2019

exact match

0 references

cites work

Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002112

7 January 2021

Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002112

7 January 2021

Vascular endothelial growth factor receptors in the regulation of angiogenesis and lymphangiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002112

7 January 2021

Sirolimus and lymphocele formation after kidney transplantation: an immunosuppressive medication as co-factor for a surgical problem?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002112

7 January 2021

Lymphedema associated with sirolimus in renal transplant recipients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002112

7 January 2021

Patterns of pulmonary complications associated with sirolimus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002112

7 January 2021

Immunosuppressive therapy with everolimus can be associated with potentially life-threatening lingual angioedema

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002112

7 January 2021

Cutaneous adverse events in renal transplant recipients receiving sirolimus-based therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002112

7 January 2021

Sirolimus-induced angioedema

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002112

7 January 2021

Targeting the molecular target of rapamycin (mTOR).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002112

7 January 2021

Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002112

7 January 2021

Rapamycin induces tumor-specific thrombosis via tissue factor in the presence of VEGF.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002112

7 January 2021

Lymphatic endothelial tumors induced by intraperitoneal injection of incomplete Freund's adjuvant.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002112

7 January 2021

Impact of cyclosporine on the development of immunosuppressive therapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002112

7 January 2021

Sirolimus for Kaposi's sarcoma in renal-transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002112

7 January 2021

Insights into the molecular pathogenesis and targeted treatment of lymphedema

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002112

7 January 2021

Vascular endothelial growth factor-C gene therapy restores lymphatic flow across incision wounds.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002112

7 January 2021

A recombinant mutant vascular endothelial growth factor-C that has lost vascular endothelial growth factor receptor-2 binding, activation, and vascular permeability activities

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002112

7 January 2021

Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002112

7 January 2021

Identifiers

DOI

10.1038/SJ.KI.5002112

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17299523%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

25 December 2019

0 references

1 reference